In a report released on November 3, Mani Foroohar from SVB Securities reiterated a Hold rating on Moderna (MRNA - Research Report), with a price target of $101.00. The company's shares closed last Friday at $158.41.According to TipRanks, Foroohar is an analyst with an average return of -15.4% and a 39.41% success rate. Foroohar covers the Healthcare sector, focusing on stocks such as Rocket Pharmaceuticals, Moderna, and BridgeBio Pharma.Moderna has an analyst consensus of Moderate Buy, with a price target consensus of $195.60, a 23.48% upside from current levels. In a report released on November 4, J.P. Morgan also maintained a Hold rating on the stock with a $120.
https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-hold-from-svb-securities?utm_source=advfn.com&utm_medium=referral